EurekaMag.com logo
+ Site Statistics
References:
52,725,316
Abstracts:
28,411,598
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Evidence of dopamine receptors in human growth hormone secreting adenomas with concomitant study of dopamine inhibition of growth hormone secretion in a perifusion system


Journal of Clinical Endocrinology & Metabolism 55(3): 589-593
Evidence of dopamine receptors in human growth hormone secreting adenomas with concomitant study of dopamine inhibition of growth hormone secretion in a perifusion system
Dopamine (DA) is known to influence human GH [growth hormone] release both in vivo and in vitro. The direct control of GH secretion at the pituitary level was observed using human GH-secreting pituitary adenomas in organ culture, but no dose-response relationship between DA and GH inhibition was demonstrated. Such a dose-response relationship was obtained using GH-secreting adenomatous cells in a perifusion column. The IC50 of DA was 5 .times. 10-8 M. Binding studies with [3H]apomorphine on human GH-secreting pituitary adenoma membranes demonstrated the presence of a dopaminergic receptor (Kd = 0.73 .+-. 0.24 nM; maximum binding, 18.5 .+-. 3.6 fmol/mg protein), which presumably mediates the effect of DA on GH release. In comparison to prior studies with PRL[prolactin]-secreting adenomas, several differences were apparent: the maximum inhibition of GH release by DA is lower than that of PRL (50% vs. 80%), the maximum number of binding sites is much lower (5-20 times) in GH-secreting adenomas than in PRL-secreting adenomas, and [3H]domperidone does not show specific binding on GH-secreting adenomas but does on PRL-secreting adenomas. The dopaminergic control of GH secretion apparently is different from that of PRL secretion, as DA is less effective on GH release than on PRL release from human pituitary adenomas.


Accession: 005411372



Related references

Evidence of dopamine receptors in human growth hormone (GH)-secreting adenomas with concomitant study of dopamine inhibition of GH secretion in a perifusion system. Journal of Clinical Endocrinology and Metabolism 55(3): 589-593, 1982

Dopamine receptors in human prolactin secreting and growth hormone secreting adenomas. Camanni, F And E E Muller (Ed ) Serono Symposia Publications From Raven Press, Vol 10 Pituitary Hyperfunction: Physiopathology And Clinical Aspects Xviii+430p Raven Press: New York, N Y , Usa Illus P111-124, 1984

In vitro effect of dopamine on growth hormone release from human growth hormone secreting pituitary adenomas. Journal of Clinical Endocrinology & Metabolism 55(4): 734-740, 1982

Dopamine inhibition of stimulated growth hormone secretion: evidence for dopaminergic modulation of insulin- and L-dopa-induced growth hormone secretion in man. Journal of Clinical Endocrinology and Metabolism 49(3): 326-330, 1979

The disappearance of paradoxical growth hormone increases to trh lhrh dopamine sulpiride as an index of full removal of growth hormone secreting adenomas. Neurochirurgia (SUPPL): 373, 1981

Dopamine inhibition of stimulated growth hormone secretion evidence for dopaminergic modulation of insulin induced growth hormone secretion in man. Clinical Research 26(5): 704A, 1978

Correlative studies between the presence of thyrotropin-releasing hormone (TRH) receptors and the in vitro stimulation of growth-hormone (GH) secretion in human GH-secreting adenomas. Hormone and Metabolic Research 17(9): 476-479, 1985

Role of dopamine in the regulation of growth hormone secretion: dopamine and bromocriptine augment growth hormone (GH)-releasing hormone-stimulated GH secretion in normal man. Journal of Clinical Endocrinology and Metabolism 64(6): 1136-1141, 1987

In vitro effect of dopamine on growth hormone (GH) release from human GH-secreting pituitary adenomas. Journal of Clinical Endocrinology and Metabolism 55(4): 734-740, 1982

Differential transduction of dopamine signal in different subtypes of human growth hormone-secreting adenomas. Journal of Clinical Endocrinology and Metabolism 78(2): 411-417, 1994